Session Information
-
WCLC 2020
2020 World Conference on Lung Cancer
Conference Program for the 2020 World Conference on Lung Cancer in Singapore
Presentation Date(s):- January 28 - 31, 2021
- Total Presentations: 1597
All times listed are in Singapore time (GMT+8)
PL - Plenary
PS - Presidential Symposium
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
FP - Featured Posters
P - Posters
IS - Industry Symposium
JICC - Joint IASLC-CAALC-CSCO Session
January 28 Thu
Jan 28 Friday
January 29 Fri
Jan 29 Saturday
January 30 Sat
Jan 30 Sunday
January 31 Sun
Jan 31
-
+
P21 - Locoregional and Oligometastatic Disease - Treatment of Locally Advanced NSCLC
- 00:00 - 00:00
- 1/28/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Locoregional and Oligometastatic Disease
-
+
P21.01 - Phase I Study of Carboplatin/Nab-Paclitaxel and Concurrent TRT in Elderly Patients with Unresectable Locally Advanced NSCLC
00:00 - 00:00 | Presenter: Shota Omori
- Abstract
Loading... -
+
P21.02 - Incidence and Outcomes of Brain Metastases in Unresectable Stage III Patients with NSCLC Treated with Durvalumab after Chemoradiation
00:00 - 00:00 | Presenter: Sandip H Patel
- Abstract
Loading... -
+
P21.03 - Dutch Lung Cancer Audit-Radiotherapy: Real-World Data on Stage III Non-Small Cell Lung Cancer Treated With Radiotherapy Only
00:00 - 00:00 | Presenter: Liselotte Van Bockel
- Abstract
Loading... -
+
P21.04 - Comparing Outcomes for Patients Receiving Chemoradiation Followed by Surgery vs. Immune Checkpoint Inhibitors in Non Small Cell Lung Cancer
00:00 - 00:00 | Presenter: Turja Chakrabarti
- Abstract
Loading... -
+
P21.05 - Overall Survival by PD-L1 Status in Stage III NSCLC Following Implementation of Durvalumab: The Real-World Application of PACIFIC
00:00 - 00:00 | Presenter: Shelley Kuang
- Abstract
Loading... -
+
P21.06 - Patterns of Post-Progression Treatment and Impact of Subsequent Immunotherapy in Stage III Unresectable Non-Small Cell Lung Cancer Patients
00:00 - 00:00 | Presenter: Sarah Shin
- Abstract
Loading... -
+
P21.07 - Immune-Related Adverse Events with Durvalumab Consolidation in a Real-World Cohort of Patients with Non–Small Cell Lung Cancer (NSCLC)
00:00 - 00:00 | Presenter: Gabriela Bravo Montenegro
- Abstract
Loading... -
+
P21.08 - Durvalumab Consolidation Following Chemoradiation for Unresectable Non-Small Cell Lung Cancer: A “Real-World” Experience.
00:00 - 00:00 | Presenter: Claire Griffiths
- Abstract
Loading... -
+
P21.09 - Does Duration of Maintenance Durvalumab Matter? Relationship between Length of Durvalumab Therapy and PFS.
00:00 - 00:00 | Presenter: Kamya Sankar
- Abstract
Loading... -
+
P21.10 - Real-World Treatment Patterns in Chinese Stage III NSCLC Patients - A Prospective, Non-Interventional Study (MOOREA trial)
00:00 - 00:00 | Presenter: Ligang Xing
- Abstract
Loading... -
+
P21.11 - Durvalumab after Concurrent cChemotherapy and High-Dose Radiotherapy in Locally Advanced Non-Small Cell Lung Cancer
00:00 - 00:00 | Presenter: Yosef Landman
- Abstract
Loading... -
+
P21.12 - An Observational Study of Treatment Outcome in Stage III Lung Cancer Patients in Taiwan: KINDLE study
00:00 - 00:00 | Presenter: Po-Lan Su
- Abstract
Loading... -
+
P21.13 - Durvalumab in Locally-Advanced NSCLC in LATAM: Real World Data from Patients Included in the Early Access Program
00:00 - 00:00 | Presenter: Florencia Tsou
- Abstract
Loading... -
+
P21.14 - The Promising role of Chemo-Immunotherapy in Non-Small Cell Lung Cancer Neoadjuvant Setting
00:00 - 00:00 | Presenter: Helena Bote
- Abstract
Loading... -
+
P21.15 - Sparing Preserved Lobes to Reduce Lung Dose for Operable IIIA NSCLC Patients Treated with Neoadjuvant Chemoradiotherapy
00:00 - 00:00 | Presenter: Hengle Gu
- Abstract
Loading... -
+
P21.16 - Do Patients who Underwent Lung Resection for Non-Small Cell Lung Cancer and Skip-N2 Metastases Show Better Survival?
00:00 - 00:00 | Presenter: Alejandra Libreros
- Abstract
Loading... -
+
P21.17 - Pneumonectomy for Locally Advanced Non-Small Cell Lung Cancer after Neoadjuvant Concurrent Chemo-Radiation Therapy
00:00 - 00:00 | Presenter: Kazunori Okabe
- Abstract
Loading...
-
+
P22 - Mesothelioma, Thymoma and Other Thoracic Malignancies - Case Reports
- 00:00 - 00:00
- 1/28/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Mesothelioma, Thymoma and Other Thoracic Malignancies
-
+
P22.01 - A Case of Intimal Sarcoma with Osteosarcomatous Differentiation
00:00 - 00:00 | Presenter: Etsuko Satoh
- Abstract
Loading... -
+
P22.02 - Outcome of Heart Rupture Repair During Huge Mediastinal Mass Resection
00:00 - 00:00 | Presenter: riad Amin Abdeljalil
- Abstract
Loading... -
+
P22.03 - Not Every FDG Avid Spot is Tumor
00:00 - 00:00 | Presenter: Isabelle Opitz
- Abstract
Loading... -
+
P22.04 - Lung Metastasis of Thyroid Transcription Factor 1 Positive Endometrioid Carcinoma; A Case Report
00:00 - 00:00 | Presenter: Masao Saito
- Abstract
Loading... -
+
P22.05 - Chest Wall and Diaphragm Reconstruction; a Technique not well Established in Literature
00:00 - 00:00 | Presenter: riad Amin Abdeljalil
- Abstract
Loading... -
+
P22.06 - A Large Solitary Fibrous Tumor of the Pleura Causing Paraneoplastic Hypoglycemia
00:00 - 00:00 | Presenter: Kohei Hashimoto
- Abstract
Loading... -
+
P22.07 - Nivolumab Immunotherapy as a Promising Therapy in Relapsed Malignant Pleural Mesothelioma
00:00 - 00:00 | Presenter: Sara Costa-Martins
- Abstract
Loading... -
+
P22.08 - Paraganglioma of the Anterior Mediastinum.
00:00 - 00:00 | Presenter: Motohisa Shibata
- Abstract
Loading...
-
+
P23 - Mesothelioma, Thymoma and Other Thoracic Malignancies - Esophageal Cancer and Rare Tumors
- 00:00 - 00:00
- 1/28/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Mesothelioma, Thymoma and Other Thoracic Malignancies
-
+
P23.01 - “Multidisciplinary Approach for the Management of Primary Tracheal Carcinoma”- Institutional Experience of 9 Bangladeshi Cases.
00:00 - 00:00 | Presenter: Qamruzzaman Chowdhury
- Abstract
Loading... -
+
P23.02 - Clinicopathological and Prognostic Features of 67 Cases With Pulmonary Sarcomatoid Carcinoma: An 18-Year Single Center Experience
00:00 - 00:00 | Presenter: Adnan Aydıner
- Abstract
Loading... -
+
P23.03 - The New Therapy on Esophageal Leiomyosarcoma in the Upper Esophagus
00:00 - 00:00 | Presenter: Chun-wei Xu
- Abstract
Loading... -
+
P23.04 - Primary Pulmonary Myxoid Sarcoma with EWSR1 Rearrangement: A Case Report
00:00 - 00:00 | Presenter: Mai Nishina
- Abstract
Loading...
-
+
P24 - Mesothelioma, Thymoma and Other Thoracic Malignancies - Mesothelioma Clinical and Trials in Progress
- 00:00 - 01:00
- 1/28/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Mesothelioma, Thymoma and Other Thoracic Malignancies
-
+
P24.01 - Entire Pleural Intensity-Modulated Radiotherapy in a Neoadjuvant Setting for Resectable Malignant Mesothelioma
00:00 - 00:00 | Presenter: Yeonsil Kim
- Abstract
Loading... -
+
P24.03 - A Multicenter Randomized Phase III Trial of Dendritic Cell Maintenance Therapy After Chemotherapy in Mesothelioma; Denim Trial
00:00 - 00:00 | Presenter: Robert Anton Belderbos
- Abstract
Loading... -
+
P24.04 - Outcome of Neoadjuvant or Adjuvant Radiotherapy in Multimodality Setting with EPP for Malignant Pleural Mesothelioma
00:00 - 00:00 | Presenter: Alireza Hoda
- Abstract
Loading... -
+
P24.05 - Malignant Mesothelioma Related to Environmental Asbestos Exposure in a Rural Area: 30-year Follow-up
00:00 - 00:00
- Abstract
Loading... -
+
P24.06 - Real World use of Cisplatin and Carboplatin Based Therapy in Patients with Malignant Pleural Mesothelioma (MPM)
00:00 - 00:00 | Presenter: Susana Cedres
- Abstract
Loading... -
+
P24.07 - Nivolumab and Ipilimumab +/- UV1 Vaccination as 2nd Line Treatment in Patients with Malignant Mesothelioma (the NIPU-Study)
00:00 - 00:00 | Presenter: Åslaug Helland
- Abstract
Loading... -
+
P24.08 - Radiological Response to TTFields Plus Chemotherapy for Malignant Pleural Mesothelioma from the Phase 2 STELLAR Trial
00:00 - 00:00 | Presenter: Federica Grosso
- Abstract
Loading... -
+
P24.09 - Pooled Safety Analysis of Clinical Trials Delivering Tumor Treating Fields (TTFields) to the Upper Torso
00:00 - 00:00 | Presenter: Federica Grosso
- Abstract
Loading...
-
+
P25 - Mesothelioma, Thymoma and Other Thoracic Malignancies - Mesothelioma Preclinical, Prognostic and Predictive Factors
- 00:00 - 00:00
- 1/28/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Mesothelioma, Thymoma and Other Thoracic Malignancies
-
+
P25.01 - Metabolic Characterization of Drug Resistance to Antifolate in Malignant Pleural Mesothelioma
00:00 - 00:00 | Presenter: Yuzo Sato
- Abstract
Loading... -
+
P25.02 - Lymph Node Metastasis of Malignant Pleural Mesothelioma
00:00 - 00:00 | Presenter: Aki Katarina Kobayashi
- Abstract
Loading... -
+
P25.03 - Novel Diagnosis Technique for Identification of Asbestos Fibres in Mesothelioma Samples using LA-ICP-MS Imaging
00:00 - 00:00 | Presenter: Oana Maria Voloaca
- Abstract
Loading... -
+
P25.04 - The Role of miRs in Determining the Response to Chemotherapy in MPM Patients Treated with Chemotherapy
00:00 - 00:00
- Abstract
Loading... -
+
P25.05 - The Brims Decision Tree Model for Prognosis in a UK Malignant Mesothelioma Group
00:00 - 00:00 | Presenter: Avinash Aujayeb
- Abstract
Loading... -
+
P25.06 - Malignant Pleural Mesothelioma: Patient Characteristics, Treatments and Outcomes from a Spanish Center
00:00 - 00:00 | Presenter: Yago Garitaonaindía
- Abstract
Loading... -
+
P25.07 - Nutritional Risk Status Predicts Outcomes of Mexican Patients with Malignant Pleural Mesothelioma
00:00 - 00:00 | Presenter: Saul Campos-Gomez
- Abstract
Loading... -
+
P25.08 - National Organisational Audit of Specialist Mesothelioma Service and Support Provision for the United Kingdom
00:00 - 00:00 | Presenter: Susan Harden
- Abstract
Loading... -
+
P25.09 - Effectiveness of Tumor Treating Fields plus Cisplatin/Pemetrexed Combination in Mesothelioma, in Vitro and in Vivo
00:00 - 00:00 | Presenter: Moshe Giladi
- Abstract
Loading... -
+
P25.10 - Computational Simulations on Safety of Tumor Treating Fields Delivered to the Lungs in Mesothelioma and NSCLC
00:00 - 00:00 | Presenter: Ze'ev Bomzon
- Abstract
Loading... -
+
P25.11 - Evaluation of the Safety of Tumor Treating Fields (TTFields) Application to the Torso – in Vivo Studies
00:00 - 00:00 | Presenter: Moshe Giladi
- Abstract
Loading... -
+
P25.12 - The Vienna Mesothelioma Inflammation Score (VMIS) is Independently Associated with Overall Survival in Malignant Pleural Mesothelioma
00:00 - 00:00 | Presenter: Berta Mosleh
- Abstract
No abstract available for this presentation
-
+
P26 - Mesothelioma, Thymoma and Other Thoracic Malignancies - Thymic Malignancies
- 00:00 - 00:00
- 1/28/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Mesothelioma, Thymoma and Other Thoracic Malignancies
-
+
P26.01 - Survival Impact of Adjuvant Postoperative Radiation Therapy (PORT) in Locally Advanced Thymic Carcinoma (TC): An Up-To-Date Meta-Analysis
00:00 - 00:00 | Presenter: Philip A. Haddad
- Abstract
Loading... -
+
P26.02 - The Impact of Clinicopathologic Factors on the Overall Survival of Thymic Neuroendocrine Tumors (TNET): A Pooled Analysis
00:00 - 00:00 | Presenter: Philip A. Haddad
- Abstract
Loading... -
+
P26.03 - The Impact of Postoperative Radiation Therapy on the Overall Survival of Resected Stage II Thymoma: An Up-to-date Meta-Analysis
00:00 - 00:00 | Presenter: Philip A. Haddad
- Abstract
Loading... -
+
P26.04 - Correlation of Somatostatin Receptor 2 Expression, DOTATATE scan and Octreotide Treatment in Thymic Epithelial Tumors
00:00 - 00:00 | Presenter: Anja C Roden
- Abstract
Loading... -
+
P26.05 - Comprehensive Genomic Sequencing in Thymic Epithelial Tumors: Identification of Multiple Poor Prognosis Biomarkers in Chinese Patients
00:00 - 00:00 | Presenter: Baohui Han
- Abstract
Loading... -
+
P26.06 - High frequency of Fatal Immune Checkpoint Inhibitor Associated Myocarditis in B2/B3 Thymoma Patients
00:00 - 00:00 | Presenter: Yue-Li Sun
- Abstract
Loading... -
+
P26.07 - Video-Assisted Thoracoscopic Surgery for Stage I Thymoma: Short-Term Outcomes and Appropriate Indications
00:00 - 00:00 | Presenter: Takahiro Suzuki
- Abstract
Loading... -
+
P26.08 - Postoperative Course of Thymoma with Myasthenia Gravis.
00:00 - 00:00 | Presenter: Fumihiko Hoshi
- Abstract
Loading... -
+
P26.09 - Is Thymomectomy alone through Video-Assisted Thoracic Surgery Appropriate for Clinical Stage I (T1N0M0) Thymoma 5cm or Less?
00:00 - 00:00 | Presenter: Kazuo Nakagawa
- Abstract
Loading... -
+
P26.10 - Molecular Characterization of Patients with Thymoma and Thymic Carcinoma
00:00 - 00:00 | Presenter: Xun Yang
- Abstract
Loading...
-
+
P27 - Nursing and Allied Health Professionals - Symptom Management
- 00:00 - 00:00
- 1/28/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Nursing and Allied Health Professionals
-
+
P27.01 - Multidisciplinary Management of Lung Cancer Patients Presenting with Oropharyngeal Dysphagia
00:00 - 00:00 | Presenter: Abigail Esther Camps
- Abstract
Loading... -
+
P27.02 - Symptom Burden and Referral to Allied Health Professionals at time of Diagnosis for Patients with Malignant Pleural Mesothelioma.
00:00 - 00:00 | Presenter: Faye Dickinson
- Abstract
Loading...
-
+
P28 - Nursing and Allied Health Professionals - Regional Roles of Nurses and Allied Health Professionals
- 00:00 - 00:00
- 1/28/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Nursing and Allied Health Professionals
-
+
P28.01 - The Clinical Pharmacist as a Member of a Multidisciplinary Team for Lung Cancer Patients Assistance
00:00 - 00:00 | Presenter: Gisele Fraga Moreira
- Abstract
Loading... -
+
P28.02 - Individualized Nutritional Management in Patients Eligible for Thoracic Surgery Experience of a Chest Tumor Center in Brazil
00:00 - 00:00 | Presenter: Imanuely Borchardt Gonçalves
- Abstract
Loading... -
+
P28.03 - An Autoethnographic Study Exploring the Role of the Lung Cancer Nurse Specialist in the National Optimal Lung Cancer Pathway
00:00 - 00:00 | Presenter: Alice Bobat
- Abstract
Loading...
-
+
P29 - Palliative and Supportive Care - Clinical Trial in Progress
- 00:00 - 00:00
- 1/28/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Palliative and Supportive Care
-
+
P29.01 - Therapeutic Thoracentesis vs Iodopovidone Pleurodesis in Malignant Pleural Effusion Secondary to Lung Cancer–Randomizedtrial
00:00 - 00:00 | Presenter: Satya Mantha Padmaja
- Abstract
Loading... -
+
P29.02 - TIP: Romiplostim for Chemo-Induced Thrombocytopenia in Adults with Solid Tumors; A P3 Randomized Placebo-Controlled Double-Blind Studies
00:00 - 00:00 | Presenter: Armando Armas
- Abstract
Loading...
-
+
P30 - Palliative and Supportive Care
- 00:00 - 00:00
- 1/28/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Palliative and Supportive Care
-
+
P30.01 - Machine Learning can be used to Predict need to see a Dietitian in Patients with Advanced Lung Cancer.
00:00 - 00:00 | Presenter: iain Phillips
- Abstract
Loading... -
+
P30.02 - Assessing SIADH (Syndrome of Inapproriate Antidiuretic Hormone Secretion) Management and Outcome Among Lung Cancer Patients: The Assert Trial
00:00 - 00:00 | Presenter: Rossana Berardi
- Abstract
Loading... -
+
P30.03 - A Simple Solution to Screening for Dietetic Need in Patients with Advanced Non-Small Cell Lung Cancer
00:00 - 00:00 | Presenter: iain Phillips
- Abstract
Loading... -
+
P30.04 - The Value of Clinical and Genetic Factors in Pain Management in EGFR Mutated Advanced Lung Adenocarcinoma Patients
00:00 - 00:00 | Presenter: Milena Cavic
- Abstract
Loading... -
+
P30.05 - Perception of Palliative Care and Prognostic Awareness of Lung Cancer Treatment in an Oncogene-Driven Lung Cancer Community
00:00 - 00:00 | Presenter: Ivy Beth Elkins
- Abstract
Loading... -
+
P30.06 - Outcome Differences Amongst Histopathological Variants of Non Small Cell Lung Cancer Treated With Palliative Radiotherapy
00:00 - 00:00 | Presenter: Abhirup Chanda
- Abstract
Loading... -
+
P30.07 - Can Response to Chemotherapy Be a Surrogate of Response to Immunotherapy in Second and Subsequent Lines- Real World Data
00:00 - 00:00 | Presenter: Ewa Celina Chmielowska
- Abstract
Loading... -
+
P30.08 - The Evaluation of Fatigue in Malignant Pleural Effusion
00:00 - 00:00 | Presenter: Avinash Aujayeb
- Abstract
Loading... -
+
P30.09 - Exposure to Antibiotics May Affect Progression-Free Survival Negatively in NSCLC Patients Receiving First-Line Chemotherapy
00:00 - 00:00 | Presenter: xiaoman Tian
- Abstract
Loading... -
+
P30.10 - Local Pulmonary Administration of Tranexamic Acid as Inhalational or Nebulized for the Control of Hemoptysis: A Systematic Review of Case Reports, Case Series, and an RCT
00:00 - 00:00 | Presenter: Lawrence Cyril Gaudiel Vitug
- Abstract
Loading... -
+
P30.11 - Psychosocial Requirements in Lung Cancer Care
00:00 - 00:00 | Presenter: Csaba Laszlo Degi
- Abstract
Loading... -
+
P30.12 - The Impact of Pacemaker and Methylprednisolone Pulse Therapy on Immune-Related Myocarditis With Complete Atrioventricular Block
00:00 - 00:00 | Presenter: Fang Wu
- Abstract
Loading... -
+
P30.13 - The Effect of Anlotinib Instead of Glucocorticoids for Encephaledema Induced by Brain Metastases in NSCLC Patients With Anti-PD1/PDL1 Therapy
00:00 - 00:00 | Presenter: Hongqing Zhuang
- Abstract
Loading...
first
prev
